GR
The Gabelli Healthcare & Wellness Trust
GRX · NYSE
$9.77 -1.21% (-$0.12)
1M -0.30%
Market Cap $146.7M
P/E Ratio 63.92x
Div. Yield 6.85%
ROE 1.37%
Bulios Fair Price
$9.6
1.7% downside
Current Price
$9.77
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GRX is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
43 /100
Fair P/S 9.60x
P/B 0.93x
P/E 63.92x
Growth
8 /100
Declining Book val. growth 8.16%
Rev. growth 0.68%
FCF growth N/A
Profitability
73 /100
Strong Op. margin 31.04%
Net margin 15.02%
FCF margin N/A
Quality
34 /100
Average ROA 0.95%
Asset turnover 0.06x
ROE 1.37%
Debt
0 /100
High Current ratio 0.03x
Debt/Assets N/A
Net debt/EBITDA N/A
Stability
28 /100
Unstable Profitable years 1
EPS volatility 564.59%
Beta 0.82x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GRX
Online
Sector
Financial Services
Industry
Asset Management
CEO
Wayne Christopher Pinsent
Employees
-
Headquarters
Rye
Upcoming events
16 SEP
Ex-Dividend
Ex-dividend date
23 SEP
Dividend Payment
Payment date